Literature DB >> 15371427

Claspin and the activated form of ATR-ATRIP collaborate in the activation of Chk1.

Akiko Kumagai1, Soo-Mi Kim, William G Dunphy.   

Abstract

Claspin is necessary for the ATR-dependent activation of Chk1 in Xenopus egg extracts containing incompletely replicated DNA. ATR possesses a regulatory partner called ATRIP. We have studied the respective roles of ATR-ATRIP and Claspin in the activation of Chk1. ATR-ATRIP bound well to various DNA templates in Xenopus egg extracts. ATR-ATRIP bound to a single-stranded DNA template was weakly active. By contrast, the ATR-ATRIP complex on a DNA template containing both single- and double-stranded regions displayed a large increase in kinase activity. This observation suggests that ATR-ATRIP normally undergoes activation upon association with specific nucleic acid structures at DNA replication forks. Without Claspin, activated ATR-ATRIP phosphorylated Chk1 weakly in a cell-free reaction. The addition of Claspin to this reaction strongly stimulated the phosphorylation of Chk1 by ATR-ATRIP. Claspin also induced significant autophosphorylation of Chk1 in the absence of ATR-ATRIP. Taken together, these results indicate that the checkpoint-dependent phosphorylation of Chk1 is a multistep process involving activation of the ATR-ATRIP complex at replication forks and presentation of Chk1 to this complex by Claspin.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15371427     DOI: 10.1074/jbc.M408353200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  60 in total

1.  Role for Rif1 in the checkpoint response to damaged DNA in Xenopus egg extracts.

Authors:  Sanjay Kumar; Hae Yong Yoo; Akiko Kumagai; Anna Shevchenko; Andrej Shevchenko; William G Dunphy
Journal:  Cell Cycle       Date:  2012-03-15       Impact factor: 4.534

2.  The conserved C terminus of Claspin interacts with Rad9 and promotes rapid activation of Chk1.

Authors:  Shizhou Liu; Na Song; Lee Zou
Journal:  Cell Cycle       Date:  2012-07-15       Impact factor: 4.534

3.  ATRIP binding to replication protein A-single-stranded DNA promotes ATR-ATRIP localization but is dispensable for Chk1 phosphorylation.

Authors:  Heather L Ball; Jeremy S Myers; David Cortez
Journal:  Mol Biol Cell       Date:  2005-03-02       Impact factor: 4.138

Review 4.  In my end is my beginning: control of end resection and DSBR pathway 'choice' by cyclin-dependent kinases.

Authors:  Ralph Scully; Anyong Xie
Journal:  Oncogene       Date:  2005-04-18       Impact factor: 9.867

5.  Unwind and slow down: checkpoint activation by helicase and polymerase uncoupling.

Authors:  David Cortez
Journal:  Genes Dev       Date:  2005-05-01       Impact factor: 11.361

6.  Roles of replication fork-interacting and Chk1-activating domains from Claspin in a DNA replication checkpoint response.

Authors:  Joon Lee; Daniel A Gold; Anna Shevchenko; Andrej Shevchenko; William G Dunphy
Journal:  Mol Biol Cell       Date:  2005-09-07       Impact factor: 4.138

7.  Claspin operates downstream of TopBP1 to direct ATR signaling towards Chk1 activation.

Authors:  Shizhou Liu; Simon Bekker-Jensen; Niels Mailand; Claudia Lukas; Jiri Bartek; Jiri Lukas
Journal:  Mol Cell Biol       Date:  2006-08       Impact factor: 4.272

8.  Phosphorylation of Xenopus Rad1 and Hus1 defines a readout for ATR activation that is independent of Claspin and the Rad9 carboxy terminus.

Authors:  Patrick J Lupardus; Karlene A Cimprich
Journal:  Mol Biol Cell       Date:  2006-01-25       Impact factor: 4.138

9.  Site-specific phosphorylation of a checkpoint mediator protein controls its responses to different DNA structures.

Authors:  Hae Yong Yoo; Seong-Yun Jeong; William G Dunphy
Journal:  Genes Dev       Date:  2006-03-17       Impact factor: 11.361

Review 10.  Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2.

Authors:  H Christian Reinhardt; Michael B Yaffe
Journal:  Curr Opin Cell Biol       Date:  2009-02-21       Impact factor: 8.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.